Keyphrases
Non-alcoholic Fatty Liver Disease (NAFLD)
100%
Advanced Fibrosis
100%
Body Mass Index
100%
Morbid Obesity
100%
Male Gender
100%
Liver Patient
100%
Fibrosis
60%
Morbidly Obese Patients
40%
High Body Mass Index
40%
Male Body
40%
Fibroscan
40%
Comorbidity
20%
Multivariate Analysis
20%
Validated Questionnaire
20%
Tel Aviv
20%
Cigarette Smoking
20%
High-risk Population
20%
Structured Questionnaire
20%
Medical Center
20%
Blood Test
20%
Medical History
20%
Hepatitis B Surface Antigen (HBsAg)
20%
Nutrition Habits
20%
Liver Fibrosis
20%
Dose-response Relationship
20%
Autoimmune Disease
20%
Alcohol Intake
20%
Liver Stiffness
20%
Significant Fibrosis
20%
Smoking Status
20%
Stiffness
20%
Obese Population
20%
Gender Education
20%
Lifestyle Habits
20%
Smoking Amount
20%
Transient Elastography
20%
Pack-years
20%
Higher Alcohols
20%
XL Probe
20%
Bariatric Clinic
20%
Serum Hepatitis
20%
Genetic Liver Disease
20%
High Stiffness
20%
Severe Fibrosis
20%
Anti-hepatitis C Virus Antibody
20%
Medicine and Dentistry
Fibrosis
100%
Nonalcoholic Fatty Liver
100%
Body Mass Index
100%
FibroScan
28%
Liver Disease
14%
Liver Fibrosis
14%
Alcohol Consumption
14%
Cross Sectional Study
14%
High Risk Population
14%
Autoimmune Disease
14%
Hepatitis C Virus
14%
Dose Response
14%
Multivariate Analysis
14%
Medical History
14%
Virus Antibody
14%
Obesity Medicine
14%
Transient Elastography
14%
Hepatitis B Antigen
14%
Cigarette Smoking
14%
Pharmacology, Toxicology and Pharmaceutical Science
Nonalcoholic Fatty Liver
100%
Fibrosis
100%
Ethanol
14%
Liver Fibrosis
14%
Cigarette Smoking
14%
Cross-Sectional Study
14%
Autoimmune Disease
14%
Liver Disease
14%
Hepatitis C Virus
14%
Medical History
14%
Virus Antibody
14%
Hepatitis B Antigen
14%